Initiation of Hepatitis C Treatment Low Among Medicaid Recipients

By Bonnie Tse August 4, 2023

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.

Direct-acting antiviral treatments for hepatitis C infection introduced in the past decade achieved cure rates consistently higher than 90 percent in clinical trials and are well tolerated. However, we’re nowhere close to reducing the burden of hepatitis C in the United States and are falling well short of the WHO target to eliminate HCV by 2030.

Shashi Kapadia, lead study author and an assistant professor of medicine in the Division of Infectious Diseases and of population health sciences at Weill Cornell Medicine.